Fazio, Maurizio http://orcid.org/0000-0003-0083-6601
Ablain, Julien
Chuan, Yan http://orcid.org/0000-0002-0449-7072
Langenau, David M. http://orcid.org/0000-0001-6664-8318
Zon, Leonard I. http://orcid.org/0000-0003-0860-926X
Article History
Accepted: 5 March 2020
First Online: 6 April 2020
Competing interests
: L.I.Z. is a founder and stockholder of Fate Therapeutics Inc., Scholar Rock and Camp4 Therapeutics Inc., and is a scientific adviser for Stemgent. The other authors declare no competing interests.